Proteome Regulatory News (PRM)

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

PROTEOME SCIENCES PLC

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

YES

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

VULPES LIFE SCIENCES FUND

4. Full name of shareholder(s)  (if different from 3.):iv

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

14 DECEMBER 2016

6. Date on which issuer notified:

15 DECEMBER 2016

7. Threshold(s) that is/are crossed orreached: vi, vii

18%

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

GB0003104196

36,573,125

36,573,125

52,973,125

52,973,125

18.00%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

% of voting rights xix, xx

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

52,973,125

18.00%

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will ceaseto hold:

12. Date on which proxy holder will cease to holdvoting rights:

13. Additional information:

executive.pa@proteomics.com 

14. Contact name:

Victoria Birse

15. Contact telephone number:

Note: Annex should only be submitted to the FCA not the issuer

Annex: Notification of major interests in share

A: Identity of the persons or legal entity subject to the notification obligation

Full name

(including legal form of legal entities)

VULPES LIFE SCIENCES FUND

Contact address

(registered office for legal entities)

c/o Maples Corporate Services Limited, PO

Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands

Phone number & email

Other useful information

(at least legal representative for legal persons)

B: Identity of the notifier, if applicable

Full name

Stephen Diggle

Contact address

One George Street #07-03 Singapore 049145

Phone number & email

Tel: (65) 6538 1998 (Main)

Email: sdiggle@vulpesinvest.com

Other useful information

(e.g. functional relationship with the person or legal entity subject to the notification obligation)

Director

C: Additional information

Email address: Complete the required TR-1 form and email it to: Major shareholdings majorshareholdings@fca.gov.uk Fax number: You can print the TR-1 form, complete it and fax it to: 020 7066 0050

For notes on how to complete form TR-1 please see the FCA website.